Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01806727 · ClinicalTrials.gov registry record · NA
Lifestyle Intervention for Treatment of Diabetes
A NA study, sponsored by Wake Forest University.
- Completed
- Registry status
- NA
- Development phase
- 260
- Enrollment target
NCT01806727: Completed NA study, sponsored by Wake Forest University.
NCT01806727 is a NA study that has completed, run by Wake Forest University. The registered enrollment target is 260 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01806727, a NA study, has completed, sponsored by Wake Forest University.
- COMPLETED
- Registry status
- NA
- Development phase
- 260 participants
- Enrollment target
Study Summary
This study is evaluating two approaches to improving the control blood sugar, and other risk factors for heart disease in overweight and obese adults with type 2 diabetes. The first approach has participants focus on weight loss via reducing food intake and increasing physical activity, while attending weekly group sessions led by trained community health workers for 12 months. The second approach has participants receive education on diabetes self management, which focuses primarily on glucose control, while attending monthly group sessions led by a study staff member for 12 months. We are recruiting persons with type 2 diabetes who live in the Winston-Salem/Forsyth County area of North Carolina who are willing to attend sessions at the Downtown Health Plaza of Wake Forest Baptist Health. We will measure risk factors for heart disease (glucose control, blood pressure, blood cholesterol) and calculate the predicted risk of heart disease, and see which intervention lowers risk to a greater extent at 12 months, as well as 24 months.
Primary Outcome
Cardiovascular risk will be estimated by the United Kingdom Prospective Diabetes Study (UKPDS) risk score, which is based on age, gender, diabetes duration, hemoglobin A1c, blood pressure, lipids, and smoking status. The study will compare the mean changes in UKDPS scores between groups at 12 months.
Interventions
- BEHAVIORAL Community Lifestyle Weight Loss (LWL)
- BEHAVIORAL Diabetes Self Management (DSM)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 260 participants |
| Start Date | 2013-04 |
| Est. Completion | 2017-03-30 |
| Phase | NA |
What the finished NCT01806727 record still lists
NCT01806727 is an interventional study that assigns participants to a tested intervention. The registered 260 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (81% lower).
The record links to 0 conditions, and to 2 interventions - of which Community Lifestyle Weight Loss (LWL) is the first listed.
NCT01806727 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01806727 about?
NCT01806727 is a clinical study titled "Lifestyle Intervention for Treatment of Diabetes". This study is evaluating two approaches to improving the control blood sugar, and other risk factors for heart disease in overweight and obese adults with type 2 diabetes. The first approach has participants focus on weight loss via reducing food intake and increasing physical activity, while attend...
What is the current status of trial NCT01806727?
This trial is currently completed. It is a NA study. The enrollment target is 260 participants. The study started on 2013-04. Estimated completion is 2017-03-30.
What interventions are being tested in trial NCT01806727?
The interventions under investigation include: Community Lifestyle Weight Loss (LWL) (BEHAVIORAL), Diabetes Self Management (DSM) (BEHAVIORAL).
Who is sponsoring clinical trial NCT01806727?
This trial is sponsored by Wake Forest University, which has 100 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01806727's enrollment target sits among peer trials
260 397th of 2000 higher than 1,601 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02283996 · 260 participants · Phase 4
Adhesive Capsulitis: Prospective Analysis of Efficacy and Financial Impact for Use of Physical Therapy in Treatment
- NCT03276793 · 260 participants · NA
Brain Connectivity in Depression
- NCT03407469 · 260 participants
Measurement of Adherence and Health-Related Quality of Life, and Health-Care Resource Utilization
- NCT03713125 · 260 participants · NA
Executive Function in Early Childhood
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia